Found 11 matching trials
An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
N/AThis is an open-label, expanded access trial designed to provide access to ...
Location
Banner MD Anderson Cancer Center
Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer
PHASE2The use of a designed viral vector that can destroy cancer cells while leav...
Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure
PHASE1The main purpose of this research study is to evaluate the safety and dosin...
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
PHASE3This is a Phase 3, open-label, randomized trial designed to evaluate the RF...
Status
Active Not Recruiting
Location
Urology Centers of Alabama PC
Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure
PHASE2To study the safety and efficacy of CG0070, an oncolytic virus expression G...
Location
Alaska Clinical Research Center
Study of CG0070 After Transurethral Resection in Patients With IR NMIBC
PHASE1Investigators will evaluate the safety of CG0070 for the treatment of patie...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin
PHASE2To evaluate the activity of intravesical administration of CG0070 and intra...
Location
University of California - San Diego
Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer
PHASE2This is an expanded access protocol to study the safety and efficacy of CG0...
Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC
PHASE1Investigators will evaluate the safety and efficacy of combination neoadjuv...
Location
Moffitt Cancer Center
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
PHASE2This is a Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate th...
Location
Mayo Clinic Arizona